The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
As India’s pharmaceutical industry moves towards becoming a 500 billion dollars global powerhouse by 2047, a new report ...
Background Drug exposure has been reported in association with Takotsubo syndrome, but the breadth and relative strength of ...
During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results